We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Methylphenidate Orifarm (methylphenidate hydrochloride) 30mg modified-release hard capsules (Sweden)
Section 19A approved medicine
Methylphenidate Orifarm (methylphenidate hydrochloride) 30mg modified-release hard capsules (Sweden)
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Current
Medicines in short supply/unavailable
RITALIN LA methylphenidate hydrochloride 30mg modified release capsule bottle - ARTG 82958
RUBIFEN LA methylphenidate hydrochloride 30 mg modified release capsules blister pack - ARTG 362232
RUBIFEN LA methylphenidate hydrochloride 30 mg modified release capsules blister pack - ARTG 362232
Indication(s)
Methylphenidate hydrochloride modified release capsules are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults and children aged 6 years and over.
Images
